Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 374 participants.

Also called NCT06013020

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 374 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06013020
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06013020. Randomized; no masking; primary purpose prevention. Start 2024-04-01 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
NOAC+DAPT
Intervention (Drug)
DAPT
Lead sponsor
Zunyi Medical College (class: other)

Record details

Record id
cardio:ct-nct06013020
Content hash
cd1ba42f10a84c5664ddd1285f0cb270baea29edb5f8cfda64ad7fe4935b7933